RCT Abstract - Treating eosinophilic exacerbations of asthma and COPD with benralizumab: a double-blind, double-dummy, active-placebo randomised controlled trial (ABRA)
Ramakrishanan S., Russell R., Mahmood H., Krassowska K., Melhorn J., Mwasuku C., Pavord I., Bermejo-Sanchez L., Howell I., Mahdi M., Peterson S., Bengtsson T., Bafadhel M.